Research map: Association between depressive symptoms, CRP and metabolism-related indicators in Han Chinese patients with chronic schizophrenia

Back to the article

Papers in this map

  1. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia · Stanley R. Kay · 1987 · 21656 citations · Cited by this paper
  2. Cohesion profiles across language-related symptoms in schizophrenia · 2026 · Related
  3. Validation of the Insomnia Severity Index as an outcome measure for insomnia research · Célyne Bastien · 2001 · 8173 citations · Cited by this paper
  4. Initiation patterns of long-acting injectable antipsychotics in a claims-based proxy cohort approximating first-episode schizophrenia: A longitudinal descriptive study using a Japanese claims database · 2026 · Related
  5. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty · Luigi Ferrucci · 2018 · 3743 citations · Cited by this paper
  6. A mixed methods study of program-level factors influencing patient and family engagement in first episode psychosis coordinated specialty care · 2026 · Related
  7. A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS · G. M. Simpson · 1970 · 3280 citations · Cited by this paper
  8. Converting negative symptom dimension scores across SANS and PANSS · 2026 · Related
  9. Prevalence of mental disorders in China: a cross-sectional epidemiological study · Yueqin Huang · 2019 · 2428 citations · Cited by this paper
  10. The U-shaped relationships between prolactin level and insulin resistance in patients with schizophrenia under olanzapine treatment · 2026 · Related
  11. A Rating Scale for Drug-Induced Akathisia · Thomas R. E. Barnes · 1989 · 2187 citations · Cited by this paper
  12. Medium-term prediction of clinically relevant outcomes in first-episode schizophrenia patients · 2026 · Related
  13. Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health · Igor Červenka · 2017 · 1404 citations · Cited by this paper
  14. Association of COVID-19 vaccination with improved treatment adherence in patients with schizophrenia: A propensity score-matched cohort study · 2026 · Related
  15. Assessing Depression in Schizophrenia: The Calgary Depression Scale · Donald Emile Addington · 1993 · 1196 citations · Cited by this paper
  16. Subjective space and time experience in schizophrenia spectrum disorders and mood disorders: Psychometric properties and clinical correlates of the semi-structured STEP interview · 2026 · Related
  17. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis · Toby Pillinger · 2019 · 1082 citations · Cited by this paper
  18. Motivation and pleasure deficits reflect altered network embedding of normal brain deviations in schizophrenia · 2026 · Related
  19. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment · Golam Mohammed Khandaker · 2015 · 947 citations · Cited by this paper
  20. Static and dynamic brain region activation abnormalities in schizophrenia: Evidence from fNIRS · 2026 · Related
  21. Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1. · Stefan Leucht · 2016 · 780 citations · Cited by this paper
  22. Impaired Glucose Homeostasis in First-Episode Schizophrenia · Toby Pillinger · 2017 · 467 citations · Cited by this paper
  23. Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders · John Alexander Williams · 2022 · 340 citations · Cited by this paper
  24. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis · Sean Halstead · 2023 · 240 citations · Cited by this paper
  25. Relationships Among Negative, Positive, and Depressive Symptoms in Schizophrenia and Psychotic Depression · Kenji W. Sax · 1996 · 233 citations · Cited by this paper
  26. An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation · Lena Brundin · 2016 · 196 citations · Cited by this paper
  27. Immunopsychiatry: important facts · Golam Mohammed Khandaker · 2017 · 188 citations · Cited by this paper
  28. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression · Kang Sim · 2004 · 151 citations · Cited by this paper
  29. Homocysteine levels in schizophrenia and affective disorders—focus on cognition · Ahmed A. Moustafa · 2014 · 149 citations · Cited by this paper
  30. Positive-negative symptom assessment in schizophrenia: Psychometric issues and scale comparison · Stanley R. Kay · 1990 · 134 citations · Cited by this paper
  31. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia · Salvador Sarró · 2003 · 100 citations · Cited by this paper
  32. The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study · Benjamin Ian Perry · 2021 · 97 citations · Cited by this paper
  33. Reliability and validity of the Chinese versions of the Scales for Assessment of Positive and Negative Symptoms · Michael Robert Phillips · 1991 · 90 citations · Cited by this paper
  34. Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia · Amira Bryll · 2020 · 80 citations · Cited by this paper
  35. Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder · Oskar Hougaard Jefsen · 2023 · 72 citations · Cited by this paper
  36. Suicide attempts are associated with activated immune-inflammatory, nitro-oxidative, and neurotoxic pathways: A systematic review and meta-analysis · Asara Vasupanrajit · 2021 · 71 citations · Cited by this paper
  37. Occurrence and treatment of depressive comorbidity/cosyndromality in schizophrenic psychoses: conceptual and treatment issues · Hans‐Jürgen Möller · 2005 · 70 citations · Cited by this paper
  38. Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): Cross-scale comparison in assessing tardive dyskinesia · Georges M. Gharabawi · 2005 · 68 citations · Cited by this paper
  39. Effects of depression on the cytokine profile in drug naïve first-episode psychosis · Cristiano de Souza Noto · 2015 · 67 citations · Cited by this paper

Source: OpenAlex (CC0)